已收盤 11-06 16:00:00 美东时间
-0.170
-0.86%
今日重点评级关注:Stifel:维持ORIC Pharmaceuticals"买入"评级,目标价从14美元升至18美元;花旗:维持Liberty Energy"买入"评级,目标价从27.5美元升至28美元
10-27 12:30
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Morgan Stanley analyst James Faucette downgraded Block Inc (NYSE:XYZ) from Overweight to Equal-We...
10-26 20:35
Raymond James analyst Michael Rose downgrades USCB Financial Holdings (NASDAQ:USCB) from Strong Buy to Outperform and lowers the price target from $25 to $23.
10-26 18:12
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• # USCB Financial Holdings 2026年第三季度业绩回顾摘要 ## 1. 财务业绩:**盈利能力:** - 净利润(Net Income):950万美元,创公司IPO以来最高季度盈利 - 稀释每股收益(Diluted EPS):0.51美元 - 前九个月累计净利润:约2,800万美元,已超过IPO以来任何完整年度的全年盈利总额 - 平均股本回报率(ROAE):16.03% - 平均资产回报率(ROAA):1.27% **净利息收入与利差:** - 净利息收入(Net Interest Income):2,430万美元 - 净息差
10-24 12:18
USCB Financial Holdings (NASDAQ:USCB) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.be...
10-23 23:55
USCB Financial Holdings (NASDAQ:USCB) reported quarterly earnings of $0.51 per share which missed the analyst consensus estimate of $0.56 by 8.93 percent. This is a 13.33 percent increase over earnings of $0.45 per share from the same period last year. The company reported quarterly sales of $26.972...
10-23 04:02
今日重点评级关注:HC Wainwright & Co.:维持Enlivex"买入"评级,目标价从20美元升至80美元;Canaccord Genuity:维持Pharming Group NV Sponsored ADR"买入"评级,目标价从37美元升至38美元
08-04 11:45
Keefe, Bruyette & Woods analyst Wood Lay maintains USCB Financial Holdings (NASDAQ:USCB) with a Outperform and raises the price target from $22 to $24.
08-04 02:14
今日重点评级关注:BTIG:上调Outlook Therapeutics"买入"评级,目标价4美元;TD Cowen:维持Nakamoto"买入"评级,目标价从1美元升至17美元
07-28 11:34
Piper Sandler analyst Stephen Scouten maintains USCB Financial Holdings (NASDAQ:USCB) with a Overweight and raises the price target from $24 to $27.
07-28 01:33